Capricor Therapeutics, Inc.
NASDAQ: CAPR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Linda Marbán
- Employees
- 231
- Headquarters
- San Diego, United States
- IPO year
- 2007
- Market cap
- $1.3B
- Website
- https://www.capricor.com
Loading CAPR…
Loading profile data…Frequently asked questions about CAPR
What does Capricor Therapeutics, Inc. (CAPR) do?
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. It...
Where does CAPR trade?
Capricor Therapeutics, Inc. (CAPR) trades on the NASDAQ.
What sector is CAPR in?
Capricor Therapeutics, Inc. (CAPR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Capricor Therapeutics, Inc.?
Linda Marbán is the chief executive officer of Capricor Therapeutics, Inc. (CAPR).
Where is Capricor Therapeutics, Inc. headquartered?
Capricor Therapeutics, Inc. is headquartered in United States.
Does CAPR pay a dividend?
Capricor Therapeutics, Inc. (CAPR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CAPR go public?
Capricor Therapeutics, Inc. (CAPR) completed its initial public offering in 2007.